427 studies found for:    United States, Vermont | University of Vermont
Show Display Options
Rank Status Study
1 Completed Re-Treatment Study of Probuphine in Opioid Addiction
Condition: Opioid Dependency
Intervention: Drug: Probuphine (buprenorphine implant)
2 Active, not recruiting Breast Mammogram and Tissue Study
Condition: Breast, Neoplasms
Intervention:
3 Recruiting Study of Late-Occurring Complications in Childhood Cancer Survivors
Conditions: Cancer Survivor;   Cardiovascular Complications;   Hematopoietic/Lymphoid Cancer;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Other: questionnaire administration;   Other: laboratory biomarker analysis
4 Terminated A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil
Condition: Alzheimer's Disease
Interventions: Drug: PRX-03140;   Drug: Placebo
5 Completed Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
Conditions: Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature;   Sepsis
Interventions: Drug: IVIG;   Drug: Placebo
6 Active, not recruiting Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Extensive Stage Small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer
Interventions: Drug: sunitinib malate;   Drug: cisplatin;   Drug: carboplatin;   Drug: etoposide;   Other: placebo;   Other: laboratory biomarker analysis
7 Recruiting Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: nicotine transdermal patch
8 Completed Internet Assisted Obesity Treatment
Conditions: Overweight;   Obesity
Intervention: Behavioral: internet, in-person and internet+in-person
9 Active, not recruiting
Has Results
Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Adult Acute Basophilic Leukemia;   Adult Acute Eosinophilic Leukemia;   Adult Acute Megakaryoblastic Leukemia (M7);   Adult Acute Minimally Differentiated Myeloid Leukemia (M0);   Adult Acute Monoblastic Leukemia (M5a);   Adult Acute Monocytic Leukemia (M5b);   Adult Acute Myeloblastic Leukemia With Maturation (M2);   Adult Acute Myeloblastic Leukemia Without Maturation (M1);   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Adult Acute Myelomonocytic Leukemia (M4);   Adult Erythroleukemia (M6a);   Adult Pure Erythroid Leukemia (M6b);   Secondary Acute Myeloid Leukemia;   Untreated Adult Acute Myeloid Leukemia
Interventions: Drug: daunorubicin hydrochloride;   Procedure: autologous bone marrow transplantation;   Drug: cytarabine;   Drug: etoposide;   Biological: filgrastim;   Drug: busulfan;   Drug: decitabine;   Procedure: autologous hematopoietic stem cell transplantation;   Other: laboratory biomarker analysis
10 Active, not recruiting Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
Conditions: Clear Cell Renal Cell Carcinoma;   Stage I Renal Cell Cancer;   Stage II Renal Cell Cancer;   Stage III Renal Cell Cancer
Interventions: Drug: sorafenib tosylate;   Drug: sunitinib malate;   Other: placebo;   Other: quality-of-life assessment;   Other: laboratory biomarker analysis
11 Recruiting Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia;   Untreated Adult Acute Lymphoblastic Leukemia
Interventions: Biological: alemtuzumab;   Drug: dasatinib;   Drug: daunorubicin hydrochloride;   Drug: fludarabine phosphate;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: in vitro-treated peripheral blood stem cell transplantation;   Drug: dexamethasone;   Drug: cyclophosphamide;   Biological: filgrastim;   Biological: pegfilgrastim;   Drug: methotrexate;   Drug: leucovorin calcium;   Drug: melphalan;   Drug: tacrolimus;   Drug: etoposide phosphate;   Drug: cytarabine;   Drug: mercaptopurine;   Drug: vincristine sulfate;   Other: pharmacological study;   Other: laboratory biomarker analysis
12 Active, not recruiting
Has Results
Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
Conditions: Contiguous Stage II Grade 1 Follicular Lymphoma;   Contiguous Stage II Grade 2 Follicular Lymphoma;   Contiguous Stage II Grade 3 Follicular Lymphoma;   Noncontiguous Stage II Grade 1 Follicular Lymphoma;   Noncontiguous Stage II Grade 2 Follicular Lymphoma;   Noncontiguous Stage II Grade 3 Follicular Lymphoma;   Stage III Grade 1 Follicular Lymphoma;   Stage III Grade 2 Follicular Lymphoma;   Stage III Grade 3 Follicular Lymphoma;   Stage IV Grade 1 Follicular Lymphoma;   Stage IV Grade 2 Follicular Lymphoma;   Stage IV Grade 3 Follicular Lymphoma
Interventions: Biological: rituximab;   Drug: lenalidomide
13 Recruiting Incentives Targeting Gestational Weight Gain in Overweight/Obese Low Income Women
Conditions: Overweight;   Obesity;   Pregnancy
Intervention: Behavioral: Financial incentives
14 Active, not recruiting Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Conditions: Stage I Wilms Tumor;   Stage II Wilms Tumor;   Stage III Wilms Tumor
Interventions: Procedure: therapeutic conventional surgery;   Drug: vincristine sulfate;   Biological: dactinomycin;   Drug: doxorubicin hydrochloride;   Radiation: 3-dimensional conformal radiation therapy
15 Not yet recruiting Project 1, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Childbearing Age Women
Condition: Tobacco Use Disorder
Intervention: Other: Very low nicotine content cigarettes
16 Terminated Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Condition: Ocular Myasthenia Gravis
Interventions: Drug: Prednisone;   Drug: Placebo
17 Active, not recruiting Not Quite Ready to Quit
Condition: Smoking Cessation
Interventions: Behavioral: Usual care;   Behavioral: Reduction;   Behavioral: 5Rs
18 Active, not recruiting
Has Results
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
Conditions: Adult Rhabdomyosarcoma;   Embryonal Childhood Rhabdomyosarcoma;   Embryonal-botryoid Childhood Rhabdomyosarcoma;   Previously Untreated Childhood Rhabdomyosarcoma
Interventions: Procedure: conventional surgery;   Drug: dactinomycin;   Drug: cyclophosphamide;   Drug: vincristine sulfate;   Radiation: radiation therapy
19 Enrolling by invitation Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Condition: Infertility
Intervention:
20 Active, not recruiting Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
Condition: Childhood Acute Lymphoblastic Leukemia in Remission
Interventions: Behavioral: compliance monitoring;   Other: study of socioeconomic and demographic variables;   Drug: mercaptopurine tablet;   Drug: methotrexate

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years